NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal

$ 7.50

4.5
(136)
In stock
Description

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Vaccines, Free Full-Text

Vaccines, Free Full-Text

Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant

Vaccine Adjuvant Clinical Evaluation

Controlled Human Infection Models To Accelerate Vaccine

Mucosal vaccines — fortifying the frontiers

Immune responses induced by different vaccine platforms against

Global Innovations (International Cooperation

The Role of Vaccines in Combating Antimicrobial Resistance

Salmonella Typhimurium expressing chromosomally integrated